IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—3 December 2013

4:32 AM MST | December 3, 2013 | Deepti Ramesh

Merck KGaA eyes pharma acquisitions in the US Merck KGaA (Darmstadt, Germany) is looking to strengthen its presence in the prescription pharmaceuticals market in the United States and is open to more collaborations and acquisitions. At a press briefing last month in Yavne, Israel, the location of Merck Serono’s subsidiary in Israel, Stefan Oschmann, board member Merck KGaA/pharma and consumer health, said that the average global pharma company generates about 50% of its sales in the US while Merck’s share is only 20%. He said that Merck is planning to...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa